Hidden Scourge: Genital Tuberculosis Strikes Young Women and Evades Diagnosis

Tuberculosis is famous for attacking the lungs, but one of its most devastating and least visible forms targets the reproductive organs of young women. A new five-year retrospective study from Shenzhen, China, published in BMC Infectious Diseases, has now mapped the clinical landscape of female genital tuberculosis (FGTB) in unusual detail, revealing a disease that hides behind gynecological complaints, mimics far more common conditions, and frequently robs women of their fertility before anyone suspects an infection. Drawing on the medical records of 5,123 female tuberculosis patients treated at a large tertiary hospital between January 2018 and December 2022, the research team identified 59 women with genital involvement and used their cases to expose the diagnostic blind spots that allow this disease to slip through the cracks.

The first striking finding is demographic. Women with FGTB were significantly younger than other female tuberculosis patients in the cohort, a difference the authors report as statistically robust with a P value below 0.001. Nearly half of the FGTB cases, 27 of 59, occurred in women aged 20 to 29 years, the very stage of life when fertility matters most. This age concentration is not incidental. The genital tract is thought to be seeded by Mycobacterium tuberculosis most often through blood-borne spread from a primary infection, and the richly vascularized fallopian tubes are particularly vulnerable. The result is a disease that preferentially strikes women in their reproductive prime, often with no history of pulmonary symptoms to raise suspicion.

Within the broader tuberculosis caseload, FGTB remained a small but persistent slice of extrapulmonary disease. The proportion of extrapulmonary tuberculosis attributable to genital involvement fluctuated between 1.36 percent and 2.39 percent across the study years, peaking in 2021. That may sound marginal, but the numbers mask a serious burden: once a woman has FGTB, the disease rarely confines itself to the reproductive organs. Abdominal tuberculosis was the most common accompanying extrapulmonary site, present in 40 of the 59 patients, or 67.80 percent. Most frequently this took the form of tuberculous peritonitis, seen in 19 patients (32.20 percent), followed by intestinal tuberculosis in 8 patients (13.56 percent). The pattern suggests that in many cases the abdomen functions as a contiguous battlefield, with infection spreading across the peritoneum to the fallopian tubes, ovaries, and uterus.

The symptom profile is where the study delivers its most clinically actionable message. In an exploratory comparison with 30 pregnant tuberculosis patients, who predominantly presented with pulmonary symptoms, the FGTB group showed dramatically higher rates of gynecological and abdominal manifestations, again with P values below 0.001. Abnormal uterine bleeding affected 15 of 59 FGTB patients, or 25.42 percent, compared with none of the pregnant controls. Abdominal pain was reported by 38.98 percent of FGTB patients versus 20.00 percent of controls, abdominal distension by 20.34 percent versus 3.33 percent, and weight loss by 11.86 percent versus none. In other words, FGTB announces itself through the abdomen and the menstrual cycle, not through cough and fever, which is precisely why it so often lands women in gynecology or gastroenterology clinics rather than tuberculosis services.

Imaging told a complementary story. Abdominal ultrasound abnormalities were specifically associated with FGTB, and the most frequent findings were ovarian changes, detected in 14 of 45 examined patients (31.11 percent), pelvic effusion in 10 patients (22.22 percent), and endometrial abnormalities in 5 patients (11.11 percent). These sonographic signatures are nonspecific on their own. Ovarian masses can suggest malignancy, pelvic fluid can accompany a long list of inflammatory conditions, and a thickened endometrium can reflect hormonal causes. But in the right clinical context, a young woman with menstrual irregularity, abdominal pain, and these ultrasound findings in a tuberculosis-endemic region, the constellation should trigger a targeted workup rather than a prolonged search for other explanations.

Diagnosis, however, is where the disease proves most stubborn. The study compared the yield of different diagnostic modalities across specimen types, and the results were sobering. Histopathological examination, typically obtained through biopsy or surgical specimens showing caseating granulomas, demonstrated the highest positivity rate by far: 32 of 35 examined samples were positive, a striking 91.43 percent. This makes tissue pathology the single most reliable diagnostic route captured in the dataset, but it also means diagnosis usually requires an invasive procedure, often laparoscopy, which is frequently performed only after other causes have been excluded and sometimes after irreversible damage has been done to the fallopian tubes.

Molecular diagnostics, the modern mainstay of tuberculosis detection elsewhere in the body, showed inconsistent performance in FGTB, with results varying depending on the sample type tested. Genital specimens are paucibacillary, meaning they contain very few bacilli, which pushes polymerase chain reaction assays toward false negatives when the bacterial load falls below the detection threshold. Acid-fast bacilli staining fared even worse, with limited utility in this setting, a familiar limitation in extrapulmonary tuberculosis where low organism density defeats microscopy. The practical consequence is a diagnostic hierarchy in which the least invasive and most widely available tests are the least useful, and the most definitive answer comes from tissue that must be surgically obtained.

The human cost of these delays is captured in the study’s conclusion about outcomes: infertility remained the predominant clinical outcome for FGTB patients. When tuberculous infection inflames and scars the fallopian tubes, it can block them permanently, and endometrial involvement can destroy the lining needed for implantation. Even after successful anti-tuberculosis therapy eradicates the bacteria, the structural damage often persists, leaving assisted reproduction through in vitro fertilization-embryo transfer as the only route to pregnancy for many survivors. Early diagnosis therefore carries a double significance: it shortens the infectious period and, more urgently for patients, it may preserve enough reproductive anatomy to keep fertility options open.

The authors’ recommendation follows directly from their data. In tuberculosis-endemic regions, FGTB should be a primary differential diagnosis in young women presenting with infertility, menstrual irregularities, abdominal pain, and abnormal pelvic imaging. That is a demanding clinical ask, because each of those features individually points toward far more common conditions, from polycystic ovary syndrome to endometriosis to pelvic inflammatory disease of bacterial origin. But the Shenzhen cohort demonstrates that the combination, particularly when paired with peritoneal involvement on imaging, should prompt clinicians to consider tuberculosis early and to pursue tissue diagnosis aggressively when noninvasive tests come back negative.

The study also carries a broader public health lesson. Tuberculosis control programs are typically organized around pulmonary disease, where cough-based screening and sputum testing work well. Extrapulmonary forms like FGTB fall outside that architecture, surfacing instead in gynecology departments, fertility clinics, and surgical wards where tuberculosis may not be on the differential at all. By quantifying how often genital tuberculosis accompanies abdominal disease, how it presents symptomatically, and which diagnostic tests actually perform, this five-year analysis gives clinicians in endemic regions a concrete profile to match against their own patients. For the young women it describes, the difference between a delayed diagnosis and an early one may determine whether they can ever carry a pregnancy, a stakes profile that makes this quiet corner of tuberculosis research anything but marginal.

Subject of Research: Clinical presentation and diagnosis of female genital tuberculosis in a retrospective hospital cohort

Article Title: Clinical spectrum and diagnostic challenges of female genital tuberculosis: a 5-year retrospective analysis

Article References: Clinical spectrum and diagnostic challenges of female genital tuberculosis: a 5-year retrospective analysis. (n.d.). https://doi.org/10.1186/s12879-026-14572-0

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14572-0

Keywords: female genital tuberculosis, tuberculosis, extrapulmonary tuberculosis, infertility, tuberculous peritonitis, histopathology, molecular diagnostics, ultrasound, Mycobacterium tuberculosis, women's health, retrospective study, China